After propensity matching 27 eyes per group, no clinically meaningful 12-month difference in haze, vision, tomography or aberrations was detected between strategies.
After matching by anterior chamber depth, no significant angle or volume difference was found between hyperopic and myopic eyes, but this does not remove caution in phakic-IOL selection.
Direct evidence was limited: no significant differences were detected in vision, predictability or safety, while faster healing with StreamLight rested on indirect comparison.
In a randomized 30-patient study, ray-tracing-guided LASIK did not increase total higher-order aberrations at three months, unlike wavefront-optimized treatment.
At six months, average visual outcomes did not differ between selected keratoconus eyes and controls. The sample was small, however, and repeat surgery occurred in both groups.
In a retrospective series of 158 eyes, retreatment improved vision and refraction, but LASIK, PRK and ICL groups differed greatly in size and were selected by clinical indication.